Ring Therapeutics Stock
HealthTechLooking to sell Ring Therapeutics stock or options?
Eligible for:
Charitable Exchange Fund
Ring Therapeutics develops medical gene therapeutics using an innovative viral vector platform designed to broaden the scope of DNA-based treatments beyond simple gene replacement. This platform targets disease sites with precision at the cellular and tissue level, addressing areas such as genetic disorders, ophthalmology, oncology, and metabolic disorders. This allows healthcare companies to deliver treatments tailored to specific diseases, utilizing a diverse range of modalities and mechanisms.
Investors Include:
The Invus Group, CJ Investment, Altitude Life Science Ventures, UPMC Enterprises, Flagship Pioneering, Alexandria Venture Investments, Kyowa Kirin, Partners Investment, T. Rowe Price Group.